Simplify Asset Management’s Eiger BioPharmaceuticals EIGR Stock Holding History
Bought
Maintained
Sold
Other funds holding EIGR
Simplify Asset Management's EIGR Position: Q2 2024 in Review
Simplify Asset Management sold out of Eiger BioPharmaceuticals (EIGR) in Q2 2024, closing a stake of 90,000 shares — an estimated $450K sold.
Simplify Asset Management first reported a position in EIGR in Q1 2023 and held it in 4 quarters. The position peaked at $986K in Q1 2023. 2 funds tracked by Wall St. Rank hold EIGR as of Q2 2024.
- Simplify Asset Management reported no remaining Eiger BioPharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Simplify Asset Management sold 90,000 Eiger BioPharmaceuticals shares in Q2 2024, an estimated $450K.
- Simplify Asset Management first reported a position in Eiger BioPharmaceuticals in Q1 2023 and held it in 4 quarters.
- Simplify Asset Management's Eiger BioPharmaceuticals position peaked at $986K in Q1 2023.
- 2 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals as of Q2 2024.
Based on Simplify Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.